Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kozo Sugimoto
Successful Collection of Peripheral Blood Stem Cells Mobilized by High-Dose Etoposide for Patients With Chemotherapy-Resistant and/or Poor Prognostic Testicular Cancer
Japanese Journal of Urology
Urology
Prognostic Factors in Patients With Renal Cell Carcinoma
Japanese Journal of Urology
Urology
Related publications
High Dose Chemotherapy With Peripheral Blood Stem Cell Transplantation for Small Cell Lung Cancer.
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Treatment of Poor-Risk Neuroblastoma Patients With High-Dose Chemotherapy and Autologous Peripheral Stem Cell Rescue
Bone Marrow Transplantation
Transplantation
Hematology
Successful Treatment of Advanced Natural Killer Cell Lymphoma With High-Dose Chemotherapy and Syngeneic Peripheral Blood Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Infectious Complications in 126 Patients Treated With High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Cyclophosphamide, Etoposide and G-CSF to Mobilize Peripheral Blood Stem Cells for Autologous Stem Cell Transplantation in Patients With Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Ifosfamide/Etoposide Alternating With High-Dose Methotrexate: Evaluation of a Chemotherapy Regimen for Poor-Risk Osteosarcoma
British Journal of Cancer
Cancer Research
Oncology
High-Dose Chemotherapy With Peripheral Blood Stem Cell Support for Stage IIIB Inflammatory Carcinoma of the Breast
Bone Marrow Transplantation
Transplantation
Hematology
Preoperative High-Dose Chemotherapy With Peripheral Blood Stem Cell Support as a Primary Management of Locally Advanced Breast Cancer
Bone Marrow Transplantation
Transplantation
Hematology
High-Dose Chemotherapy With Carboplatin, Etoposide and Ifosfamide Followed by Autologous Stem Cell Rescue in Patients With Relapsed or Refractory Malignant Lymphomas: A Phase I/Ii Study
Bone Marrow Transplantation
Transplantation
Hematology
